Jennifer Tremblay-Mercier

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains (Quesnel et al., 2024)

Citation : Quesnel, M. J., Labonté, A., Picard, C., Zetterberg, H., Blennow, K., Brinkmalm, A., Villeneuve, S., Poirier, J., Alzheimer’s Disease Neuroimaging Initiative , & PREVENT-AD Research Group (2024). Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains. Brain : a journal of neurology, 147(5), 1680–1695. https://doi.org/10.1093/brain/awad398 Full text : Here Insulin-like […]

Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains (Quesnel et al., 2024) Read More »

Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. (Quesnel et al., 2024)

Citation : Quesnel et al., (2024). Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. Alzheimer’s & Dementia. Full text : Here Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease Quesnel M.J, Labonté A, Picard C, Bowie D.C, Zetterberg H, Blennow K, Brinkmalm A, Villeneuve S, Poirier J, Alzheimer’s Disease Neuroimaging Initiative, PREVENT-AD research group.

Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer’s disease. (Quesnel et al., 2024) Read More »